NFKB1 and Miyoshi myopathy: Simultaneous treatment of MM cells with cannabidiol and bortezomib prevents cell growth and cell cycle progression, induces cells death via the activation of ERK, AKT, and NF-κB pathways, and triggers mitochondrial- and ROS-dependent necrosis [92].